Can Fite BioPharma Ltd (CANF)

[midastouch017]

Can-Fite to Exhibit at Bio International Convention in San Francisco on June 6-9, 2016

PETACH TIKVA, Israel, June 3, 2016 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today announced the Company will exhibit at the Bio International Convention on June 6-9, 2016, in San Francisco at the Israel Office of the Chief Scientist's booth. Dr. Sari Fishman, the Company's Director of Business Development, will conduct one-on-one meetings with potential big pharma and biotech partners at the convention. In addition, Dr. Fishman will be part of an Israeli Biotech Delegation participating in a satellite event titled, Perspectives on Biotech Investing on June 6, where Can-Fite will participate in a pitch session for attendees interested in Israel's biotech economy and companies.

The BIO International Convention (BIO) attracts over 15,000 biotechnology and pharma leaders who come together for intensive networking to discover new opportunities and promising partnerships. This event covers a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.